Tenet Healthcare (THC Quick QuoteTHC - Free Report) reported $5.37 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 2.8%. EPS of $4.82 for the same period compares to $4.36 a year ago.

The reported revenue represents a surprise of -0.36% over the Zacks Consensus Estimate of $5.39 billion. With the consensus EPS estimate being $4.21, the EPS surprise was +14.39%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Adjusted patient admissions - Same-hospital: 210.85 thousand versus 212.31 thousand estimated by two analysts on average.
• Adjusted admissions: 215.35 thousand versus the two-analyst average estimate of 208.48 thousand.
• Net Operating revenues: $5.37 billion versus the four-analyst average estimate of $5.37 billion. The reported number represents a year-over-year change of +2.8%.
• Net Operating revenues- Ambulatory Care: $1.32 billion compared to the $1.3 billion average estimate based on four analysts. The reported number represents a change of +10.6% year over year.
• Net Operating revenues- Hospital Operations and Services: $4.05 billion versus the four-analyst average estimate of $4.07 billion. The reported number represents a year-over-year change of +0.5%.
• Equity in earnings of unconsolidated affiliates: $51 million versus $57.66 million estimated by four analysts on average.
• Equity in earnings of unconsolidated affiliates- Ambulatory Care: $51 million compared to the $55.55 million average estimate based on three analysts.
• Adjusted EBITDA- Hospital Operations and Services: $678 million versus the three-analyst average estimate of $622.37 million.
• Adjusted EBITDA- Ambulatory Care: $484 million versus $487.14 million estimated by three analysts on average.

View all Key Company Metrics for Tenet here>>>

Shares of Tenet have returned -5.4% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.